Port Catheter Product Liability Lawsuits
Case Overview
Thousands of individuals have initiated product liability lawsuits against Bard and AngioDynamics. These claims center on the allegation that certain implanted port catheters, including Bard PowerPort and AngioDynamics SmartPort, contained design flaws. These alleged defects could lead to device failure, migration, or contribute to severe medical issues for patients.
The lawsuits assert that the manufacturers were aware of the potential risks associated with these devices but failed to provide adequate warnings to both patients and healthcare providers. The claims involve injuries such as catheter fractures, blood clots, and infections, which can result in further medical procedures and lasting health consequences.
Federal litigation involving these manufacturers is ongoing, with multiple MDLs active. Individuals who received an eligible port catheter for cancer treatment and suffered complications are advised to complete a form to determine their eligibility to pursue a lawsuit. Filing deadlines vary by state and depend on when the injury occurred or was discovered.
Who May Qualify
Patients who received specific Bard or AngioDynamics port catheters within the past 10 years for cancer treatment and experienced complications such as a catheter fracture, migration, blood clot, or infection.